Log in to save to my catalogue

KK-LC-1 as a therapeutic target to eliminate ALDH+ stem cells in triple negative breast cancer

KK-LC-1 as a therapeutic target to eliminate ALDH+ stem cells in triple negative breast cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4a6a3bc37dc04129b0d0a57674aa4a99

KK-LC-1 as a therapeutic target to eliminate ALDH+ stem cells in triple negative breast cancer

About this item

Full title

KK-LC-1 as a therapeutic target to eliminate ALDH+ stem cells in triple negative breast cancer

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2023-05, Vol.14 (1), p.2602-2602, Article 2602

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Failure to achieve complete elimination of triple negative breast cancer (TNBC) stem cells after adjuvant therapy is associated with poor outcomes. Aldehyde dehydrogenase 1 (ALDH1) is a marker of breast cancer stem cells (BCSCs), and its enzymatic activity regulates tumor stemness. Identifying upstream targets to control ALDH
+
cells may faci...

Alternative Titles

Full title

KK-LC-1 as a therapeutic target to eliminate ALDH+ stem cells in triple negative breast cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4a6a3bc37dc04129b0d0a57674aa4a99

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4a6a3bc37dc04129b0d0a57674aa4a99

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-023-38097-1

How to access this item